Pharmaceutical Risk-Sharing Arrangements Can Reduce Drug Costs for Payers

Study in Non–Small Cell Lung Cancer Using Real-World Data

Lawrenceville, NJ, USA—March 25, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that pharmaceutical risk-sharing arrangements can mitigate uncertainty around the budget impact of drugs, but only when the type of arrangement matches the setting and type of uncertainty. The report, “Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data,” was published in the March 2019 issue of Value in HealthRead more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

Canadian Public Places High Priority on Drugs’ Safety, Effectiveness, and Certainty of Evidence

Survey Reveals Top Values for Drug Coverage Decision Making

Lawrenceville, NJ, USA—March 25, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that Canadians believe drug coverage decision makers should prioritize safety, effectiveness, and strong evidence. The report, “Evaluating Canadians’ Values for Drug Coverage Decision Making,” was published in the March 2019 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

“Top 10 Trends in Health Economics and Outcomes Research” Webinar Announced

ISPOR’s Chief Science Officers to Report on Top Trends Impacting Healthcare

Lawrenceville, NJ, USA—March 4, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR), announced a new webinar on the ISPOR 2019 Top 10 HEOR Trends report that was published earlier this year. The free webinar will be held on March 22, 2019 at 12:00PM EDT and is open to both ISPOR members and non-members. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

Global Experts Call for Robust Approaches to Measure Adherence to Complex Medication Regimens

No Current Standardized Method to Measure Multiple Medication Adherence

 

Lawrenceville, NJ, USA—February 12, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research suggesting that there is no standardized method to measure adherence to multiple medications (ie, “multiple medication adherence,” or MMA), nor is there agreement between researchers on how to use a specific existing measure to calculate MMA. The report, “Methods for Measuring Multiple Medication Adherence: A Systematic Review—Report of the ISPOR Medication Adherence and Persistence Special Interest Group,” was published in the February 2019 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Systematic Reviews, Value in Health Tagged with: , , ,

Paying Low-Income Smokers to Quit? New Study Shows Financial Incentives for Tobacco Quit Phone Line Engagement Are Cost-Effective

Lawrenceville, NJ, USA—February 12, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that the use of financial incentives to encourage engagement with tobacco quit line treatment is a cost-effective option to enhance smoking cessation rates for low-income smokers. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

“Medical Nutrition” Is Poorly Defined, Insufficiently Assessed

Report from the ISPOR Nutrition Economics Special Interest Group

Lawrenceville, NJ, USA—February 11, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research—announced today the publication of an ISPOR scoping review showing that “medical nutrition” terminology is not consistently defined, relevant European and US regulations are infrequently cited, and economic evaluations are infrequently conducted. The report, “Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group,” was published in the January 2019 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

ISPOR Warsaw 2019 Announced for 27-28 March

Conference to Center on HEOR Issues in Central and Eastern Europe


Lawrenceville, NJ, USA—February 5, 2019—ISPOR—the professional society for health economics and outcomes research—announced a new regional conference, ISPOR Warsaw 2019, scheduled for 27-28 March 2019 in Warsaw, Poland. The conference will center on health economics and outcomes research (HEOR) issues in Central and Eastern Europe with the theme, “Navigating Joint Health Technology Assessment, Procurement, and Fair Pricing: Evidence-Based Insights and Practical Recommendations.” The conference will bring together regional and international experts and stakeholders in HEOR to share innovative research methods and health policy developments. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR’s Digital Initiatives Awarded Multiple AVA Digital Awards

ISPOR’s Website and HTA Central Site Recognized for Excellence

Lawrenceville, NJ, USA—January 29, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), has been awarded multiple AVA Digital Awards in recognition of several digital campaigns. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with:

Leading Global Experts Identify Good Practices in the Use of Evidence to Inform Decision Making for Health Technologies

ISPOR Working Group on Good Practices in HTA Provides First Major Synthesis Report in 20 Years

Lawrenceville, NJ, USA—January 21, 2019—ISPOR—the professional society for health economics and outcomes research—announced today the publication of the first report in 20 years to comprehensively synthesize good practices in health technology assessment (HTA)—intended to support population-based decision making for pharmaceuticals, medical devices, and other health technologies. Read more ›

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , , , ,